Call Us: 888-488-5750

VativoRx and Cooperton to Exhibit at the Puerto Rico Hospital Association Convention 2025

VativoRx and its sister company, Cooperton, are proud to announce their joint participation as exhibitors at the Puerto Rico Hospital Association Convention, taking place October 29–31, 2025, in San Juan, Puerto Rico.

Together, both companies bring a unique value proposition to Puerto Rico’s healthcare community—combining financial optimization through Strategic Rebate Management with next-generation cybersecurity and IT resilience designed specifically for healthcare institutions.

VativoRx will showcase its Medical & Pharmacy Rebate Program, a compliance-driven solution that helps hospitals and outpatient facilities recover unclaimed manufacturer rebates on high-cost specialty drugs under Medicare Parts A and B. Through advanced analytics, secure HITRUST-certified data exchange, and rigorous audit validation, VativoRx empowers providers to strengthen financial performance without disrupting care delivery.

Cooperton, a leader in cybersecurity, digital infrastructure, and enterprise IT solutions, will highlight how its healthcare technology services protect mission-critical data and ensure business continuity. The company’s participation underscores the growing importance of cybersecurity in the healthcare landscape—where data protection and operational integrity are now inseparable from financial sustainability.

As part of the convention agenda, William Bonaparte, Chief Operating Officer of Cooperton, will present the session:

“Tecnologías Emergentes y Ciberseguridad en el Sector Salud: Retos y Oportunidades para 2026”
(October 30, 3:00–3:30 PM)

Exploring how artificial intelligence and digital risk management are shaping cybersecurity governance and operational efficiency in healthcare institutions.

Healthcare executives, IT leaders, and financial decision-makers are invited to visit VativoRx and Cooperton at Booths #78–79 to explore how both companies are helping hospitals across Puerto Rico improve compliance, reduce risk, and uncover new revenue streams through secure, data-driven solutions.

To schedule a meeting during the event, contact us or cooperton.

When Drug Negotiation Reaches Part B

For years, Medicare drug price negotiation was mostly discussed as a Part D story. That changed in January, when CMS selected 15 drugs for the third cycle of negotiation, including the first drugs payable under Medicare Part B. Negotiations take place in 2026, and any negotiated prices from this cycle take effect in 2028.

Read More »

TrumpRx: What It Is and What to Watch

TrumpRx.gov has quickly become part of the national conversation on prescription affordability. For provider organizations, the value in tracking TrumpRx isn’t political; it’s operational. Programs like this can influence patient expectations, pricing conversations at the point of care, and the way stakeholders interpret “drug cost” when list, net, and out-of-pocket prices don’t align.

Read More »